CSX Forecast, price target & analysts
CSX Target price 2025 - Analyst rating & recommendation
CSX Classifications & Recommendation:
CSX Price Target
| Target Price | $39.78 |
| Price | $32.51 |
| Potential | 22.36% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target CSX 2026 . The average CSX target price is $39.78. This is 22.36% higher than the current stock price. The highest price target is $47.25 45.34% , the lowest is $27.27 16.12% . | |
| A rating was issued by 32 analysts: 22 Analysts recommend CSX to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the CSX stock has an average upside potential 2026 of 22.36% . Most analysts recommend the CSX stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2030
27 Analysts have issued a sales forecast CSX 2025 . The average CSX sales estimate is $14.4b . This is 1.57% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $15.0b 6.29% , the lowest is $13.8b 2.24% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $14.5b | 0.80% |
|---|---|---|
| 2025 | $14.4b | 1.12% |
| 2026 | $15.0b | 4.56% |
| 2027 | $15.6b | 3.85% |
| 2028 | $16.3b | 4.13% |
| 2029 | $17.0b | 4.74% |
| 2030 | $17.4b | 2.14% |
26 Analysts have issued an CSX EBITDA forecast 2025. The average CSX EBITDA estimate is $6.6b . This is 2.59% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.1b 9.08% , the lowest is $6.1b 5.08% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $7.0b | 1.02% |
|---|---|---|
| 2025 | $6.6b | 5.11% |
| 2026 | $7.2b | 8.64% |
| 2027 | $7.6b | 5.67% |
| 2028 | $8.1b | 6.49% |
| 2029 | $8.5b | 4.35% |
EBITDA Margin
| 2024 | 48.14% | 0.22% |
|---|---|---|
| 2025 | 46.20% | 4.04% |
| 2026 | 48.00% | 3.90% |
| 2027 | 48.84% | 1.75% |
| 2028 | 49.95% | 2.27% |
| 2029 | 49.77% | 0.36% |
29 CSX Analysts have issued a net profit forecast 2025. The average CSX net profit estimate is $3.1b . This is 1.29% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.4b 9.55% , the lowest is $3.0b 4.00% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $3.5b | 5.40% |
|---|---|---|
| 2025 | $3.1b | 9.45% |
| 2026 | $3.6b | 15.99% |
| 2027 | $4.0b | 10.73% |
| 2028 | $4.4b | 9.97% |
| 2029 | $4.9b | 10.46% |
| 2030 | $5.4b | 10.63% |
Net Margin
| 2024 | 23.87% | 4.64% |
|---|---|---|
| 2025 | 21.85% | 8.44% |
| 2026 | 24.24% | 10.94% |
| 2027 | 25.85% | 6.64% |
| 2028 | 27.30% | 5.61% |
| 2029 | 28.79% | 5.46% |
| 2030 | 31.18% | 8.30% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
29 Analysts have issued a CSX forecast for earnings per share. The average CSX EPS is $1.69 . This is 2.42% higher than earnings per share in the financial year 2024. The highest EPS forecast is $1.82 10.30% , the lowest is $1.60 3.03% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $1.79 | 1.65% |
|---|---|---|
| 2025 | $1.69 | 5.59% |
| 2026 | $1.95 | 15.38% |
| 2027 | $2.16 | 10.77% |
| 2028 | $2.38 | 10.19% |
| 2029 | $2.63 | 10.50% |
| 2030 | $2.91 | 10.65% |
P/E ratio
| Current | 19.70 | 7.02% |
|---|---|---|
| 2025 | 19.29 | 2.10% |
| 2026 | 16.63 | 13.79% |
| 2027 | 15.02 | 9.68% |
| 2028 | 13.66 | 9.05% |
| 2029 | 12.36 | 9.52% |
| 2030 | 11.18 | 9.55% |
Based on analysts' sales estimates for 2025, the CSX stock is valued at an EV/Sales of 5.52 and an P/S ratio of 4.22 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 5.61 | 0.53% |
|---|---|---|
| 2025 | 5.52 | 1.58% |
| 2026 | 5.28 | 4.36% |
| 2027 | 5.08 | 3.71% |
| 2028 | 4.88 | 3.96% |
| 2029 | 4.66 | 4.52% |
| 2030 | 4.56 | 2.10% |
P/S ratio
| Current | 4.28 | 4.07% |
|---|---|---|
| 2025 | 4.22 | 1.54% |
| 2026 | 4.03 | 4.36% |
| 2027 | 3.88 | 3.71% |
| 2028 | 3.73 | 3.96% |
| 2029 | 3.56 | 4.52% |
| 2030 | 3.49 | 2.10% |
Current CSX Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BMO Capital |
Outperform
➜
Market Perform
|
Downgrade | Aug 18 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Jul 25 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 24 2025 |
| Benchmark |
Buy
➜
Buy
|
Unchanged | Jul 24 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 24 2025 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Jul 24 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
BMO Capital:
Outperform
➜
Market Perform
|
Aug 18 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Jul 25 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 24 2025 |
|
Unchanged
Benchmark:
Buy
➜
Buy
|
Jul 24 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 24 2025 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Jul 24 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Jul 24 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
